Acelyrin

Developer of drugs for immunology

placeLos Angeles, California, United States calendar_todayFounded 2020 groups113 employees language acelyrin.com

Registered entities

Innovation

7 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 47 times.

YearFilings
20233
20241
20257
20262

Investor mix

15 investors on record; lead investors include Westlake Village Biopartners, Citadel, AyurMaya, Access Industries.

Investor typeCountShare
Venture capital853%
Private equity17%
Bank & private debt17%
Other / undisclosed533%
Coming soon